Alterity Therapeutics (ATHE) Stock Off Session High: Gets New Patent

August 4, 2021

A biotechnology company developing disease-modifying treatments for neurodegenerative conditions, Alterity Therapeutics (NASDAQ:ATHE) on August 4, 2021 announced the United States Patent and Trademark Office issuing Notice of Allowance for Alterity’s patent application No. 17/239,375. This would secure exclusivity for a fresh group of iron chaperones made for redistributing the excess iron in many neurodegenerative diseases, including Parkinson’s and Alzheimer’s. The patent, which is titled “Compounds for and Methods of Treating…

Read More >>